| 000 | 01030 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516050020.0 | ||
| 264 | 0 | _c20111201 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2011.04278.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGebbink, M F B G | |
| 245 | 0 | 0 |
_aTissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cJul 2011 |
||
| 300 |
_a174-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aHemostasis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlasminogen _xdrug effects |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xpharmacology |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 9 Suppl 1 _gp. 174-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2011.04278.x _zAvailable from publisher's website |
| 999 |
_c21028072 _d21028072 |
||